Cargando…

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database: Erratum

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017261/ http://dx.doi.org/10.1097/01.md.0000473517.85992.17

Ejemplares similares

Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database
por: Lee, Meng-Tse Gabriel, et al.
Publicado: (2015)

A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae
por: Zahari, Nurul Izzaty Najwa, et al.
Publicado: (2023)

Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis
por: Lee, Jong Hoo, et al.
Publicado: (2017)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
por: Liu, Sitong, et al.
Publicado: (2019)

Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients
por: Aldhahri, Raghad K., et al.
Publicado: (2022)

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae
por: Demczuk, Walter, et al.
Publicado: (2022)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

Comparative Effectiveness of Different Oral Antibiotics Regimens for Treatment of Urinary Tract Infection in Outpatients: An Analysis of National Representative Claims Database
Publicado: (2015)

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
por: Bolhuis, Mathieu S., et al.
Publicado: (2011)

Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study
por: Lin, Kuan-Yin, et al.
Publicado: (2015)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota
por: Gu, Si-Lan, et al.
Publicado: (2020)

Different Dynamic Patterns of β-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial Diversity
por: Yin, Jia, et al.
Publicado: (2015)

β-Lactam Antibiotics Renaissance
por: Qin, Wenling, et al.
Publicado: (2014)

β-Lactam Allergy in Children
por: Suleyman, Ayse, et al.
Publicado: (2021)

β-Lactams from the Ocean
por: Fisher, Jed F., et al.
Publicado: (2023)

1795. Safety Outcomes of the Use of β-Lactam Therapy in Patients With Documented β-Lactam Allergy
por: Bjork, Lauren
Publicado: (2018)

Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics
por: Kim, Si Won, et al.
Publicado: (2018)

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
por: Sutton, Jesse D., et al.
Publicado: (2020)

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006)

Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea
por: Knecht, Henrik, et al.
Publicado: (2014)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
por: Ul Haq, Shahbaz, et al.
Publicado: (2022)

Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring
por: Kim, Yoonjung, et al.
Publicado: (2022)

Dataset of response characteristics of H(2)-producing bacteria consortium to β-lactams, aminoglycosides, macrolides, quinolones antibiotics
por: Xiao, Dong, et al.
Publicado: (2022)

Accuracy in diagnosis of allergy to β-lactams
por: Iglesias-Souto, Javier, et al.
Publicado: (2012)

Regulation and compartmentalization of β‐lactam biosynthesis
por: Martín, Juan F., et al.
Publicado: (2010)

Occupational allergy to β-lactam antibiotics
por: Classen, Anna, et al.
Publicado: (2015)

Optimizing β-Lactams against Tuberculosis
por: de Jager, Veronique R., et al.
Publicado: (2020)

Hypersensitivity to non-β-lactam antibiotics
por: Merk, Hans F., et al.
Publicado: (2022)

Antipseudomonal β-Lactams Resistance in Iran
por: Rabiei, Mohammad Mahdi, et al.
Publicado: (2020)

Structural Insights for β-Lactam Antibiotics
por: Kim, Dogyeoung, et al.
Publicado: (2023)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
por: Luci, Giacomo, et al.
Publicado: (2021)

Multidrug Resistance Profiles and Resistance Mechanisms to β-Lactams and Fluoroquinolones in Bacterial Isolates from Hospital Wastewater in Bangladesh
por: Manik, Rasel Khan, et al.
Publicado: (2023)

High Serum β-Lactams Specific/Total IgE Ratio Is Associated with Immediate Reactions to β-Lactams Antibiotics
por: Vultaggio, Alessandra, et al.
Publicado: (2015)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

Susceptibility to β-lactams and quinolones of Enterobacteriaceae isolated from urinary tract infections in outpatients
por: Marchisio, Martín, et al.
Publicado: (2015)

Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2023)

Clinically Relevant β-Lactam Resistance Genes in Wastewater Treatment Plants
por: Waśko, Izabela, et al.
Publicado: (2022)

β-Lactam Resistance and Enterobacteriaceae, United States
por: Whichard, Jean M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_s96ngmul7jkredb765o517pjkr